Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iraq Healthcare Wire.
Press releases published on September 2, 2025
UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office
GlobeNewswire
·
September 2, 2025
NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL during symposium presentation with leadership from Rockefeller Capital and Matthew Rockefeller. Company has recently raised $8. …
Chronic Gout Market to Witness Strong Growth by 2034 Owing to the Expected Launch of Therapies including mTOR Inhibitors and URAT1 Inhibitors | DelveInsight
GlobeNewswire
·
September 2, 2025
New York, USA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Chronic Gout Market to Witness Strong Growth by 2034 Owing to the Expected Launch of Therapies including mTOR Inhibitors and URAT1 Inhibitors | DelveInsight The chronic gout market is expected to maintain a …
QHSLab (OTCQB: USAQ) Rolls Out Breakthrough Pediatric Screening Tool Linking Allergies and Mental Health
GlobeNewswire
·
September 2, 2025
Back-to-School Season Just Got Smarter The Pediatric Health Assessment empowers parents and providers to uncover hidden health or behavioral issues that may affect academic and social success. QHSLab’s platform delivers critical insights at the perfect …
Lighthouse Autism Center Affirms Commitment to Nebraska Families Following Medicaid Rate Cuts
GlobeNewswire
·
September 2, 2025
MISHAWAKA, Ind., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lighthouse Autism Center announced today it will continue to provide Applied Behavior Analysis (ABA) therapy to Nebraska families despite a recent 48% reduction in Medicaid reimbursement rates for direct …
Precipio Terminates Its ATM
GlobeNewswire
·
September 2, 2025
NEW HAVEN, Conn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), has terminated its ATM (At-The-Market) instrument with investment bank Alliance Global Partners (AGP). “Our Company is in a much …
Perfusion Life Approved as GSA Vendor, Enhancing Cardiac Perfusion Staffing for VA Hospitals
GlobeNewswire
·
September 2, 2025
Raleigh, North Carolina, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Perfusion Life, a nationally recognized provider of joint-commission accredited perfusion staffing, has been approved as a vendor on the General Services Administration (GSA) schedule. This …
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
GlobeNewswire
·
September 2, 2025
DUBLIN, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has …
Ethos Cannabis and Thomas Jefferson University to Co-Host Pennsylvania Medical Marijuana Education & Research Summit
GlobeNewswire
·
September 2, 2025
As Pennsylvania’s Cannabis Market Evolves, Shapiro Administration Deputy Secretary Meghna Patel and Other Experts Lead Dialogue on Medical Cannabis Policy, Research, and Patient Access Summit to Take Place on September 5, 2025, at Thomas Jefferson …
Senti Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, …
Grand River Aseptic Manufacturing (GRAM) Appoints Denis Johnson as Chief Executive Officer
GlobeNewswire
·
September 2, 2025
Grand Rapids, Michigan, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Grand River Aseptic Manufacturing (“GRAM” or the “Company”), a portfolio company of Arlington Capital Partners, today announced the promotion of Denis Johnson to Chief Executive Officer, effective …
Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum
GlobeNewswire
·
September 2, 2025
MELBOURNE, Australia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today …
Windtree Therapeutics Stockholders Approve Key Proposals for Revenue and Profit Generation at the Special Stockholder Meeting
GlobeNewswire
·
September 2, 2025
The Special Stockholder Meeting on August 28, 2025 recorded the proxy voting approvals of all ten of the Windtree proposals by stockholders The stockholder approved proposals provide the foundation for Windtree revenue generating deals in environmental …
Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios
GlobeNewswire
·
September 2, 2025
--Existing investors, including Femasys’ largest shareholders, reaffirm confidence in Femasys’ strategy for growth and impact in women’s health-- ATLANTA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making …
KidneyVault Perfusion Technology Expands the Donor Pool by Increasing Access to Medically Complex Kidneys
GlobeNewswire
·
September 2, 2025
WALTHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Paragonix Technologies, a leader in advanced organ preservation and transplant logistics, reports an extraordinary case at the Tampa General Hospital Transplant Institute in which a donor kidney underwent …
Top U.S. Honor Roll Hospital Expands Use of INSPIRA™ ART100 System to Lung Transplant Procedures
GlobeNewswire
·
September 2, 2025
RA'ANANA, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that a top U. …
Predicine Submits First Module of PMA Application to FDA for PredicineCARE™ as a Companion Diagnostic Assay in Bladder Cancer
GlobeNewswire
·
September 2, 2025
HAYWARD, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Predicine, Inc., a leading molecular insights company, today announced the submission of the first module of its premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for …
Silexion Therapeutics to Present at the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
GlobeNewswire
·
September 2, 2025
Grand Cayman, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced that …
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital
GlobeNewswire
·
September 2, 2025
NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL during symposium presentation with leadership from Rockefeller Capital and Matthew Rockefeller. Company has recently raised $8. …
Digital Utilities Ventures Accelerates Global Growth with Breakthrough Clean Water and Sustainable Agriculture Technologies
GlobeNewswire
·
September 2, 2025
Company advancing commercialization with new contracts, installations, and manufacturing expansion Modular technologies designed for recurring revenue and scalable international growth Proven blueprint guiding global expansion MANKATO, Minn., Sept. 02, …
Outlook Therapeutics Requests Type A Meeting with FDA
GlobeNewswire
·
September 2, 2025
ISELIN, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today announced that a Type A Meeting …